Kelsey Klute, M.D.

Klute-2016-002.JPGKelsey Klute, M.D.
Assistant Professor, Internal Medicine
Division of Oncology & Hematology

Academic office mailing address:
UNMC Oncology/Hematology Division
986840 Nebraska Medical Center
Omaha, NE 681980-6840

Main Academic Ph. 402-559-8500
New Patient Referral Ph. 402-559-5600
Fax 402-559-6520

Practice locations:
Fred & Pamela Buffett Cancer Center
505 South 45th Street
Omaha, NE 68105 (map)

Nebraska Medicine Village Pointe
111 North 175th Street
Omaha, NE 68118
Ph. 402-596-3100 (map)

Education:
Weill-Cornell Medical College/New York Presbyterian Hospital in New York, NY – Clinical Fellowship in Medical Oncology and Hematology (2016)
Washington University/Barnes-Jewish Hospital in St. Louis, MO – Residency in Internal Medicine  (2013)
University of North Dakota – School of Medicine and Health Sciences in Grand Forks, ND – MD (2010)
University of Minnesota – Twin Cities in Minneapolis, MN – BA/BS (2006)

Hospital Appointments:
Nebraska Medicine

Interests:
Clinical care of patients with gastrointestinal cancers; Research in novel therapies/clinical trials in gastrointestinal cancers, particularly pancreatic cancer; cancer cachexia

Biographical Sketch:

Select Publications:
Klute K, Nackos E, Tasaki S, Nguyen DP, Bander NH, Tagawa ST.  Microtubule inhibitor-based antibody-drug conjugates for cancer therapy.  OncoTargets and Therapy.  2014; 2104(7):2227-2236.

Klute K
, DeFilippis E, Shillingford K, Chapin J, DeSancho M.  Clinical presentations, risk factors, treatment and outcomes in patients with splanchnic vein thrombosis: A single-center experience.  Journal of Thrombosis and Thrombolysis. 2016:1-5.

Klute K
, Brouwer J, Jhawer M, Sachs H, Gangadin A, Ocean A, Popa E, Dai T, Wu G, Christos P, Shah M.  Chemotherapy dose intensity predicted by baseline nutrition assessment in gastrointestinal malignancies: A multicenter analysis.  European Journal of Cancer. 2016;63:189-200.

Chapin J, Klute K, Christos P, DeSancho M.  The safety of chronic antithrombotic therapy in patients with factor XI deficiency.  British Journal of Haematology.  2016 Jul 8 [Epub ahead of print].

Schneider BJ, Shah MA, Klute K, Ocean A, Popa E, Schreiner A, Christos P, Mercado A, Palmer R, Port J, Altorki N, Scandura J.  Phase I study of epigenetic priming using 5-azacytidine prior to neoadjuvant chemotherapy in patients with resectable esophageal and gastric adenocarcinoma.  (Accepted – Clinical Cancer Research)

Additional Publications at PubMed.Gov: https://www.ncbi.nlm.nih.gov/pubmed